Welcome to PRI

Founded in 2002, PRI at Albany College of Pharmacy and Health Sciences is a center for drug discovery and development

EXPERTISE   Nanotechnology, Medicinal Chemistry, Molecular Biology, Cell Biology

FOCUS   Hematology/Oncology, Cardiovascular (Dyslipidemia), Ophthalmology, Vascular diseases, Neurology, Inflammation

TEACHING and LEARNING   Pharmacy students, graduate students, visiting scholars from around the world visit PRI to conduct research and learn the latest advances across a wide range of therapeutic areas

Congratulations Dr Mousa !

Shaker A. Mousa has been elected Fellow of the National Academy of Inventors (NAI) – class of 2018!  Election to NAI Fellow status is the highest professional distinction accorded to academic inventors who have demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development and the welfare of society. The 2018 NAI Fellows class will be inducted at the Space Center Houston in April at the Eighth Annual Meeting of the NAI.

1-Day Nanomedicine Conference on ACPHS Campus

September 17, 2018 – View the full brochure and schedule 

No registration fee, breakfast & lunch included, awards for best student posters

Dr. Paul Davis selected as Top Endocrine Pharmacologist for 2018 by the International Association of Top Professionals (IAOTP) for his outstanding leadership and commitment to the profession.

Dr. Davis is Adjunct Professor of Pharmacy at the Albany College of Pharmacy and Health Sciences and a Professor of Medicine at Albany Medical College.


Dr. Mousa is serving as Co-chairman of the

First International Conference on

Nanotechnology: Theory and Applications

Cairo, Egypt, December 10-13, 2018


There will be 4 main tracks: Nanomedicine, Nano for Energy,

Nano for Industry, Water Food and Environment

The 8th Annual Research Forum was held on Jan. 27, 2018 at ACPHS, featuring Keynote Speakers, talks,  posters in a variety of disciplines.

View the Annual Research Forum Agenda 2018

PRI Executive Director Wins the Kuwait Prize

Congratulations Dr. Mousa !

Dr. Shaker Mousa has been named a 2017 recipient of the Kuwait Prize, one of the world’s most prestigious awards for achievements in science.

* * * Watch a video highlighting Dr. Mousa’s career accomplishments* * *

Sponsored by the Kuwait Foundation for the Advancement of Sciences (KFAS), this annual award recognizes lifetime contributions of Arab scientists across the globe. Dr. Mousa was honored in the category of Applied Sciences (Applied Medical & Applied Allied Health Sciences). The Kuwait Prize was first awarded in 1979. Award recipients are selected based on evaluations from local and international scientific institutions.

It is my great honor to receive the Kuwait Prize for Applied Sciences, and I wish to thank the KFAS for using this awards program to stimulate interest in the scientific community and help inspire further advances,” said Dr. Mousa. “I truly believe that science knows no boundaries. The only chance we have to find better therapies for complex diseases is for the global scientific community to work together, and I value being part of that process.”

PRI Celebrates 15 Years !!

Left to Right: W. Li, K. Godugu, S.A. Mousa, P. Phillips. M. Jayaraman, D. Bharali, S. Thangirala,

M. Rajabi, B. Hay, K. Keating, O. Karakus

Recent Publications

  • Tetraiodothyroacetic acid (tetrac), integrin alphavbeta3 and disabling of immune checkpoint defense

    PJ Davis, SA Mousa, H-Y Lin
    Editorial: Tetraiodothyroacetic acid (tetrac), integrin alphavbeta3 and disabling of immune checkpoint defense. Future Medicinal Chemistry. 2018;10(14):1637-1639.

    Read more
  • Synthesis of new analogs of tetraiodothyroacetic acid (tetrac) as novel angiogenesis inhibitors for treatment of cancer

    M Rajabi, M Yalcin M, SA Mousa
    Synthesis of new analogs of tetraiodothyroacetic acid (tetrac) as novel angiogenesis inhibitors for treatment of cancer. Bioorganic & Medicinal Chemistry Letters 2018;28(7):1223-1227.

    Read more